课题基金 / 基金详情

New Drug and Technology Assessment in Bladder Cancer: Creation of a Novel Canadian Policy Model for Bladder Cancer

New Drug and Technology Assessment in Bladder Cancer: Creation of a Novel Canadian Policy Model for Bladder Cancer
膀胱癌新药物和技术评估：创建加拿大膀胱癌新政策模型
批准号：
379031
负责人：
Kulkarni Girish S
金额：
$7.29万
依托单位：
University Health Network (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-10-01 至 2018-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=379031&lang=en
关键词：
Bladder Cancer Cost-Effectiveness Policy Population Data

项目摘要

项目成果

Kulkarni Girish S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Introduction: Bladder cancer (BCa) is currently one of the most expensive cancers to treat, and with many promising but costly therapies emerging, BCa treatment costs are expected to increase even further. As a result, research that assesses how to effect
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Drug and Technology Assessment in Bladder Cancer: Creation of a Novel Canadian Policy Model for Bladder Cancer
  • 批准号：
    420558
  • 项目类别：
    Operating Grants
  • 资助金额：
    $49.54万
  • 财政年份：
    2020
  • 负责人：
    Kulkarni Girish S
  • 依托单位：
    University Health Network (Toronto)
海外基金